Minimally invasive surgery For Lung Cancer has achieved major breakthroughs. Assisted by thoracoscopy, it only requires a small incision of 3 cm. It reduces the need for blood transfusion—95% of patients do not require transfusion. The operation time is shortened to within 2 hours, and the hospital stay is reduced from two weeks to one week. It improves the radicality of the surgery, increasing the 5-year survival rate by 6% and significantly enhancing the quality of life.

Malignant tumors are one of the major diseases seriously threatening human health and life, Based on existing evidence-based medical evidence, combined with domestic and international guidelines and consensuses, the Chinese Anti-Cancer Association (CACA) has formulated these Guidelines for the Clinical Application of Malignant Tumor Immunotherapy Technologies, aiming to provide assistance to clinicians engaged in clinical immunotherapy.